Richard Godfrey is the founder of BerGenBio. BerGenBio has raised $75M in total funding. Latest round: IPO. Backed by Investinor AS, Meteva AS.
Richard Godfrey is the CEO of BerGenBio ASA, a Norwegian biotechnology company founded in 2007 in Bergen that focuses on developing innovative medicines for aggressive diseases. He has led the company through significant capital events, including a $50 million IPO on the Oslo Stock Exchange in April 2017 and a subsequent $25 million private placement in 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library